Physician

Diana J Galindo, M.D.

According to 2025 Medicare claims, Diana Galindo, M.D. (NPI: 1497718522) practices geriatric medicine in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is CLEVELAND CLINIC FLORIDA A NONPROFIT CORPORATION (NPI: 1215989298; TIN: 340714585) and primary practice location at 33331-3502. Galindo is affiliated with the Cleveland Clinic Florida Integrated Health (ACO ID: A3588), participating under the MSSP model.

Galindo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 148 traditional Medicare patients, billed 1,139 HCPCS/CPT codes, and received $39,300 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,788 prescription claims across 350 beneficiaries totaling $173,908 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 105 claims. Open Payments data shows 8 records totaling $272. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $211,463 to $39,300. Similarly, Part D prescription costs have fallen sharply in recent years, from $645,063 to $173,908. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $6,198 and ending at $2,443.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$106K$211K2015 Medicare payment: $211,463 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $187,866 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $180,583 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $182,717 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $195,979 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $153,222 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $122,408 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $108,543 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $67,499 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $39,300 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156813,742$211,463
20166914,034$187,866
20176353,664$180,583
20185804,094$182,717
20195304,701$195,979
20204063,892$153,222
20213723,763$122,408
20223663,088$108,543
20232821,889$67,499
20241481,139$39,300

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$324K$649K2015 Drug cost: $645,063 (USD; Tot_Drug_Cst)2016 Drug cost: $648,958 (USD; Tot_Drug_Cst)2017 Drug cost: $554,140 (USD; Tot_Drug_Cst)2018 Drug cost: $432,488 (USD; Tot_Drug_Cst)2019 Drug cost: $393,114 (USD; Tot_Drug_Cst)2020 Drug cost: $331,203 (USD; Tot_Drug_Cst)2021 Drug cost: $310,270 (USD; Tot_Drug_Cst)2022 Drug cost: $307,565 (USD; Tot_Drug_Cst)2023 Drug cost: $187,276 (USD; Tot_Drug_Cst)2024 Drug cost: $173,908 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201588011,052$645,063
201684610,558$648,958
20178129,268$554,140
20187087,472$432,488
20197186,860$393,114
20206166,216$331,203
20215055,557$310,270
20226956,003$307,565
20234864,076$187,276
20243502,788$173,908

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$6.9K$14K2015 Medicare payment: $13,431 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $13,865 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $5,811 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $9,079 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $12,920 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $13,855 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $9,020 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,706 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $5,763 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201564382$13,431
201650326$13,865
201744226$5,811
201830163$9,079
201928182$12,920
202015193$13,855
202112116$9,020
2022N/R58$1,706
2023N/R105$5,763
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more5581$45
G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit9494$41
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more109226$34
G0444Annual depression screening, 5 to 15 minutes5353$19
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more3237$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban591,524$26,767
JardianceEmpagliflozin29538$11,410
EntrestoSacubitril/Valsartan14454$10,428
GabapentinGabapentin542,890$4,147
CreonLipase/Protease/Amylase28549$4,095

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.8$272Novo Nordisk Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Diana J. Galindo, M.D.?

Tedicare shows public-source Medicare data for Diana J. Galindo, M.D. (NPI 1497718522), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Diana J. Galindo, M.D. have ACO affiliation data?

Diana J. Galindo, M.D. is shown with ACO affiliation data for Cleveland Clinic Florida Integrated Health (MSSP, ACO ID A3588).

What billing organization is linked to Diana J. Galindo, M.D.?

Diana J. Galindo, M.D. is linked to CLEVELAND CLINIC FLORIDA A NONPROFIT CORPORATION (billing NPI 1215989298) in the available physician profile data.

Does Diana J. Galindo, M.D. have Open Payments data?

Diana J. Galindo, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.